It is of paramount importance to increase our understanding of the molecular basis like disrupted pathways of this cancer to refine the clinical decision-making process.
(45– 47) Although it is common to consider conventional cytotoxic chemotherapy as an immunosuppressive modality, more recent studies have indicated that some cytotoxic drugs have the ability to disrupt pathways of immune suppression and immune tolerance in a manner that depends on the drug type, its dose, and the treatment schedule in relation to the immune-based intervention.
Finally, although our study focused on the discovery of disrupted pathways from datasets of copy number alterations, the algorithm is general and can be readily applied to other types of genomic data, including, gene expression, mutation, and methylation.
We also investigated the commonly disrupted pathways in terms of their enrichment for known cancer-related genes.
We first explored patterns of disrupted pathways by using two-way hierarchical clustering to identify clusters of pathways that are statistically co-disrupted.
These observations suggest that commonly disrupted pathways across many types of cancers could play a major role in the development of cancers, while the set of disrupted pathways that are specific to certain types of cancers could help to characterize these types of cancers and provide options for different targeted therapies.
Thus, NetPathID is uniquely suitable for providing a global analysis of disrupted pathways across cancers.
We hypothesized that commonly disrupted pathways across many types of cancers have many cancer "driver" genes as key components.
We also provide a network view of disrupted pathways to show how copy number alteration can disrupt core pathways that are essential for cancer development and progression.
We also provide a network view of disrupted pathways to explain how copy number alterations affect pathways that regulate cell growth, cycle, and differentiation for tumorigenesis.
Saporin lesion of MS, DBN (horizontal limb), or MS + DBN had no anticonvulsant effects, suggesting that aspiration lesion of MS disrupted pathways beyond cholinergic ones.
